SCHEMBL25631

SCHEMBL25631

O=C(ON1C(=O)CCC1=O)c1cccc2c1C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 10/20 0.50
MAPT P10636 3/20 0.50
HPGD P15428 2/20 0.50
MEN1 O00255 2/20 0.50
HTT P42858 2/20 0.50
KMT2A Q03164 2/20 0.50
CYP2C19 P33261 1/20 0.50
RECQL P46063 1/20 0.50
BLM P54132 1/20 0.50
SMAD3 P84022 1/20 0.50
PRMT1 Q99873 1/20 0.50
ACE2 Q9BYF1 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
ALDH1A1 P00352 2/20 0.48
ALOX12 P18054 2/20 0.48
CYP2C9 P11712 1/20 0.48
ALOX15 P16050 1/20 0.48
BRCA1 P38398 1/20 0.48
HSD17B10 Q99714 1/20 0.48
LMNA P02545 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5490543 0.86 HPGD (0.34) FTOMAPTHPGDMEN1HTT
SCHEMBL20339897 0.85 FTO (0.53) FTOMAPTHPGDMEN1HTT
SCHEMBL1228074 0.85 ALDH1A1 (0.58) FTOMAPTHPGDMEN1HTT
SCHEMBL6843543 0.84 HPGD (0.46) FTOMAPTHPGDMEN1HTT
SCHEMBL6850491 0.82 FTO (0.60) FTOMAPTHPGDMEN1HTT
SCHEMBL30064563 0.81 FTO (0.56) FTOMAPTHPGDMEN1HTT
SCHEMBL29501272 0.81 FTO (0.56) FTOMAPTHPGDMEN1HTT
SCHEMBL29995636 0.81 FTO (0.56) FTOMAPTHPGDMEN1HTT
SCHEMBL164316 0.81 FTO (0.56) FTOMAPTHPGDMEN1HTT
SCHEMBL20832 0.81 ALDH1A1 (0.60) FTOMAPTHPGDMEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 8452 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260116981-A1 NOVEL COMBINATION AND USE OF ANTIBODIES BIOINVENT INT AB (SE) 2026-04-30 US claimed
US-20260041688-A1 COMPOSITIONS COMPRISING REGULATORY T CELLS AND METHODS OF MAKING AND USING THE SAME CELLENKOS INC (US) 2026-02-12 US claimed
EP-4562125-A1 ACTIVATION INDUCED MARKER ASSAY The University of Birmingham (GB) 2025-06-04 EP claimed
EP-3807635-B1 METHOD FOR STRATIFYING THE RISK OF BK VIRUS NEPHROPATHY AFTER A KIDNEY TRANSPLANT UNIV PARIS SACLAY (FR) 2025-04-09 EP claimed
CN-119744345-A Compositions and methods for single well multiple calibration and compensation 弹弓生物科学公司 2025-04-01 CN claimed
US-20250084452-A1 BIOLOGICAL INDICATOR FOR DETERMINING THE EFFICACY OF A STERILIZATION PROCESS AND METHODS OF USE TERRAGENE LLC 2025-03-13 US claimed
EP-3730943-B1 B-CELL ANTIGEN PRESENTING CELL ASSAY UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION (US) 2025-01-29 EP claimed
US-20250014709-A1 INTELLIGENT DESIGN METHOD OF TYPE I DIABETES VACCINE SHANGHAI INSTITUTE FOR ADVANCED STUDY ZHEJIANG UNIV (CN) 2025-01-09 US claimed
US-20250003993-A1 METHODS AND KITS FOR IDENTIFYING AND QUANTIFYING STORAGE-INDUCED MICROERYTHROCYTES Institut National de la Santé et de la Recherche Médicale (FR) 2025-01-02 US claimed
CN-118995568-A Construction method and application of cholestasis organ model 北京清华长庚医院 2024-11-22 CN claimed
WO-2011112634-A2 MOLECULAR INDICIA OF CELLULAR CONSTITUENTS AND RESOLVING THE SAME BY SUPER-RESOLUTION TECHNOLOGIES IN SINGLE CELLS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2011-09-15 WO claimed
EP-2316036-A2 STIMULATED CELL STANDARDS Health Protection Agency (GB) 2011-05-04 EP claimed
EP-2217269-A2 VACCINE NANOTECHNOLOGY Massachusetts Institute of Technology (US) 2010-08-18 EP claimed
WO-2010090873-A2 POLYPEPTIDES AND THEIR USE AS ADJUVANTS UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) 2010-08-12 WO claimed
WO-2010042852-A2 T-CELL-BASED IDENTIFICATION OF TISSUE ANTIGENS RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG (DE) 2010-04-15 WO claimed
WO-2010004336-A2 STIMULATED CELL STANDARDS HEALTH PROTECTION AGENCY (GB) 2010-01-14 WO claimed
WO-2009146495-A1 METHOD FOR PREDICTING ENGRAFTMENT POTENTIAL SYDNEY WEST AREA HEALTH SERVICES (AU) 2009-12-10 WO claimed
WO-2009051837-A2 VACCINE NANOTECHNOLOGY MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2009-04-23 WO claimed
EP-0673392-B1 METHOD OF PREFERENTIAL LABELLING OF PHYCOBILIPROTEIN WITH AMINE-REACTIVE DYE FOR USE IN A MULTIPLE COLOR ASSAY COULTER INT CORP (US) 2003-04-02 EP claimed
US-5783673-A CONTROLLING STOICHIOMETRY FOR UNIFORM PRODUCT, PRESENCE OF SALT, PREVENTION OF QUENCHING COULTER CORPORATION (US) 1998-07-21 US claimed